by Jen Hodson | May 1, 2019 | Press Release
NK-92® Cell Based Bioanalytical Solutions are the Key to Optimizing R&D and Commercial Product Development Efforts for Monoclonal Antibodies, Bi-Specifics and Related Biological Products SAN DIEGO–May 1, 2019– Brink Biologics, Inc., a NantKwest,...
